4 April 2016 - CADTH has received notice of pending submissions from Boehringer Ingelheim for empagliflozin with metformin hydrochloride (Synjardy) for use by patients with type 2 diabetes mellitus and from Servier for amlodipine besylate with perindopril arginine (Viacoram) for use by patients with hypertension.

For more details, go to:https://www.cadth.ca/empagliflozin-and-metformin [Synjardy]